Troponin Thresholds for Risk Stratification of Chest Pain Patients Presenting to the Emergency Department: Alternatives to the 99th Percentile
Open Access
- 2 November 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
Abstract
Background: Two methods are used to determine cardiac troponin (cTn) thresholds for high-risk stratification for myocardial infarction (MI), namely the assay’s healthy population 99th percentiles and a threshold that has a positive predictive value (PPV) of about 70%. We hypothesized that these methods may produce inconsistent prediction of MI risk. Methods: We compared the positive likelihood ratio (LR+), sensitivity, and specificity at 99th percentiles and published high-risk thresholds for a high-sensitivity (hs) cTnI (Abbott) and cTnT (Roche) assay. We simulated the high-risk threshold derivation methodology that derives thresholds with 70% PPV as a function of prevalence and sample size. We derived and validated thresholds based on LR+ = 20 and specificity = 95%. Results: In 2584 patients there was an almost 2-fold difference in LR+ between males and females at the sex-specific 99th percentiles, and a 2- to 3-fold difference between assays. Thresholds giving 70% PPV were much higher in lower-prevalence cohorts for both assays, being 3- to 10-fold lower at 5% than 20% prevalence. Thresholds derived using a LR+ or specificity had similar performance in a validation cohort between sexes but had a 2-fold difference in LR+ in a validation cohort between assays. Conclusions: In patients presenting to the emergency department with possible MI, sex-specific 99th percentile thresholds convey lower risk of MI for females than males. Risks also differed between assays. Risk thresholds derived using the PPV vary considerably with the prevalence and size of cohort. Thresholds derived with specificity or positive likelihood ratio had more consistent risk-prediction.Keywords
Funding Information
- Christchurch Heart Institute
- Emergency Care Foundation
- British Heart Foundation (PG/24/12136)
- Health Research Council of New Zealand
- Upstream Medical Technologies
This publication has 40 references indexed in Scilit:
- Clinical Decisions and Outcomes After Switching High-Sensitivity Cardiac Troponin Assays in Suspected ACSJAMA Cardiology, 2026
- Implementation of a High-Sensitivity Cardiac Troponin Assay and Diagnostic Protocol for Suspected Acute Coronary SyndromeThe American Journal of Cardiology, 2025
- High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource UseJAMA Network Open, 2024
- Personalized diagnosis in suspected myocardial infarctionClinical Research in Cardiology, 2023
- Early kinetic profiles of troponin I and T measured by high-sensitivity assays in patients with myocardial infarctionClinica Chimica Acta, 2020
- Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting – Results from the Linz Troponin (LITROP) studyClinica Chimica Acta, 2018
- Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within PracticeAnnals of Emergency Medicine, 2016
- Two-hour Algorithm for Triage Toward Rule-out and Rule-in of Acute Myocardial Infarction Using High-sensitivity Cardiac Troponin TThe American Journal of Medicine, 2015
- A 2-Hour Diagnostic Protocol for Possible Cardiac Chest Pain in the Emergency DepartmentJAMA Internal Medicine, 2014
- Chest pain in the emergency room: value of the HEART scoreNetherlands Heart Journal, 2008